Deep Research.
Original Thinking.
Three original books by C.J. Sinclair exploring the frontiers of AI, markets, and human performance. Each includes the full PDF ebook and complete audiobook narration.
C.J. Sinclair · Vetta Research
The Alchemist's Algorithm
How Artificial Intelligence Is Reinventing Drug Discovery
Explore how artificial intelligence is transforming pharmaceutical research, from target identification to clinical trials. This deep dive reveals the algorithms, companies, and breakthroughs reshaping the $1.4 trillion drug discovery pipeline — and the investment opportunities they create.
C.J. Sinclair · Vetta Research
The Golden Lining
Why Bear Markets Are the Best Time to Build Generational Wealth
History's greatest fortunes were built during market downturns. This book reveals the contrarian strategies, psychological frameworks, and data-driven approaches that turn fear into generational wealth — drawing on two decades of Vetta's proprietary research.
C.J. Sinclair · Vetta Research
The Brain's Ctrl+Alt+Del
Psychedelic Microdosing, Neuroplasticity, and the Coming Cognitive Revolution in the Workplace
At the intersection of neuroscience, psychedelic research, and workplace performance lies a paradigm shift. This book examines the science of microdosing, neuroplasticity, and cognitive enhancement — and what it means for investors, entrepreneurs, and knowledge workers.
Get All Three for $19
Save $8 compared to buying individually. All three PDFs and audiobooks — instant download.
The Alchemist's Algorithm
C.J. Sinclair
The Golden Lining
C.J. Sinclair
The Brain's Ctrl+Alt+Del
C.J. Sinclair
Secure checkout via Stripe · Instant download · PDF + Audiobook
Get All 3 Books Free
All three ebooks and audiobooks are included as a bonus when you subscribe to Vetta Alpha Growth — along with the live 20-stock portfolio, monthly rebalancing signals, and the full research library. Starting at $19/month.
Subscribe to Alpha GrowthDisclaimer: These publications are for informational and educational purposes only. They do not constitute investment advice. Past performance is not indicative of future results. Please read our full Disclosure.